{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T05:09:25Z","timestamp":1725426565983},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,5,4]],"date-time":"2006-05-04T00:00:00Z","timestamp":1146700800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1186\/1471-2261-6-21","type":"journal-article","created":{"date-parts":[[2006,5,4]],"date-time":"2006-05-04T18:22:32Z","timestamp":1146766952000},"source":"Crossref","is-referenced-by-count":4,"title":["Revascularization and cardioprotective drug treatment in myocardial infarction patients: how do they impact on patients' survival when delivered as usual care"],"prefix":"10.1186","volume":"6","author":[{"given":"Alain","family":"Vanasse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josiane","family":"Courteau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Th\u00e9ophile","family":"Niyonsenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,5,4]]},"reference":[{"key":"112_CR1","volume-title":"Le Fardeau croissant des maladies cardiovasculaires et des accidents vasculaires c\u00e9r\u00e9braux au Canada","author":"Fondation des maladies du Coeur","year":"2003","unstructured":"Fondation des maladies du Coeur: Le Fardeau croissant des maladies cardiovasculaires et des accidents vasculaires c\u00e9r\u00e9braux au Canada. 2003, Ottawa, Canada"},{"issue":"22","key":"112_CR2","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1001\/jama.283.22.2941","volume":"283","author":"CP Cannon","year":"2000","unstructured":"Cannon CP, Gibson CM, Lambrew CT, Shoultz DA, Levy D, French WJ, Gore JM, Weaver WD, Rogers WJ, Tiefenbrunn AJ: Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA. 2000, 283 (22): 2941-7. 10.1001\/jama.283.22.2941.","journal-title":"JAMA"},{"issue":"3","key":"112_CR3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0002-9149(98)00342-7","volume":"82","author":"RJ Goldberg","year":"1998","unstructured":"Goldberg RJ, Mooradd M, Gurwitz JH, Rogers WJ, French WJ, Barron HV, Gore JM: Impact of time to treatment with tissue plasminogen activator on morbidity and mortality following acute myocardial infarction (The second National Registry of Myocardial Infarction). Am J Cardiol. 1998, 82 (3): 259-64. 10.1016\/S0002-9149(98)00342-7.","journal-title":"Am J Cardiol"},{"key":"112_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0735-1097(90)90575-A","volume":"16","author":"RM Gunnar","year":"1990","unstructured":"Gunnar RM, Passamani ER, Bourdillon PD, Pitt B, Dixon DW, Rapaport E, Fuster V, Reeves TJ, Karp RB, Russell RO, Guidelines for the early management of patients with acute myocardial infarction, et al: A report of the American College of Cardiology\/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures. J Am Coll Cardiol. 1990, 16: 249-292.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"112_CR5","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1001\/jama.287.10.1269","volume":"287","author":"RH Mehta","year":"2002","unstructured":"Mehta RH, Montoye CK, Gallogly M, Baker P, Blount A, Faul J, Roychoudhury C, Borzak S, Fox S, Franklin M, Freundl M, Kline-Rogers E, LaLonde T, Orza M, Parrish R, Satwicz M, Smith MJ, Sobotka P, Winston S, Riba AA, Eagle KA, for the GAP Steering Committee of the American College of Cardiology: Improving quality of care for acute myocardial infarction: the guidelines applied in practice (GAP) initiative. JAMA. 2002, 287 (10): 1269-76. 10.1001\/jama.287.10.1269.","journal-title":"JAMA"},{"issue":"3","key":"112_CR6","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S0735-1097(99)00351-4","volume":"34","author":"TJ Ryan","year":"1999","unstructured":"Ryan TJ, Antman EM, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapaport E, Riegel B, Russell RO, Smith EE, Weaver WD, Gibbons RJ, Alpert JS, Eagle KA, Gardner TJ, Garson A, Gregoratos G, Ryan TJ, Smith SC: 1999 update: ACC\/AHA guidelines for the management of patients with acute myocardial infarction. A report of the ACC\/AHA Task Force on practice guidelines. J Am Coll Cardiol. 1999, 34 (3): 890-911. 10.1016\/S0735-1097(99)00351-4.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"112_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3810\/pgm.1997.09.319","volume":"102","author":"BK Whisenant","year":"1997","unstructured":"Whisenant BK, Wolfe CL: Acute myocardial infarction. Recommendations for medical management and primary angioplasty. Postgrad Med. 1997, 102 (3): 159-72.","journal-title":"Postgrad Med"},{"issue":"11","key":"112_CR8","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/S0002-9149(02)02320-2","volume":"89","author":"D Antoniucci","year":"2002","unstructured":"Antoniucci D, Valenti R, Migliorini A, Moschi G, Trapani M, Buonamici P, Cerisano G, Bolognese L, Santoro GM: Relation of time to treatment and mortality in patients with acute myocardial infarction undergoing primary coronary angioplasty. American Journal of Cardiology. 2002, 89 (11): 1248-1252. 10.1016\/S0002-9149(02)02320-2.","journal-title":"American Journal of Cardiology"},{"issue":"2","key":"112_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ancard.2004.07.003","volume":"54","author":"A Chodek","year":"2005","unstructured":"Chodek A, Angioi M, Fajraoui M, Moulin F, Chouihed T, Maurer P, Mejean C, Carteaux JP, Popovic B, Piquemal R, Ethevenot G, Aliot E: Facteurs pronostiques de mortalite chez les patients en \u00e9tat de choc cardiogenique primaire traites par angioplastie en phase aigue d'infarctus. Annales de Cardiologie et d Angeiologie. 2005, 54 (2): 74-79. 10.1016\/j.ancard.2004.07.003.","journal-title":"Annales de Cardiologie et d Angeiologie"},{"issue":"10","key":"112_CR10","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1161\/01.CIR.0000121424.76486.20","volume":"109","author":"G De Luca","year":"2004","unstructured":"De Luca G, Suryapranata H, Ottervanger JP, Antman EM: Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. [see comment]. Circulation. 2004, 109 (10): 1223-1225. 10.1161\/01.CIR.0000121424.76486.20.","journal-title":"Circulation"},{"issue":"10","key":"112_CR11","doi-asserted-by":"publisher","first-page":"994","DOI":"10.4065\/75.10.994","volume":"75","author":"JL Velianou","year":"2000","unstructured":"Velianou JL, Wilson SH, Reeder GS, Caplice NM, Grill DE, Holmes DR, Bell MR: Decreasing mortality with primary percutaneous coronary intervention in patients with acute myocardial infarction: the Mayo Clinic experience from 1991 through 1997. [see comment]. Mayo Clinic Proceedings. 2000, 75 (10): 994-1001.","journal-title":"Mayo Clinic Proceedings"},{"issue":"2","key":"112_CR12","first-page":"136","volume":"5","author":"G Steffenino","year":"2004","unstructured":"Steffenino G, Santoro GM, Maras P, Mauri F, Ardissino D, Violini R, Chiarella F, Lucci D, Marini M, Baldasseroni S, Maggioni AP: In-hospital and one-year outcomes of patients with high-risk acute myocardial infarction treated with thrombolysis or primary coronary angioplasty. Ital Heart J. 2004, 5 (2): 136-45.","journal-title":"Ital Heart J"},{"issue":"4","key":"112_CR13","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0002-9149(02)02499-2","volume":"90","author":"F Ar\u00f3s","year":"2002","unstructured":"Ar\u00f3s F, Marrugat J, L\u00f3pez-Bescos L, Cabad\u00e9s A, Loma-Osorio A, Bosch X, the PRIAMHO Investigators: Accessibility to coronary angiography and one-year survival after myocardial infarction. Am J Cardiol. 2002, 90 (4): 409-12. 10.1016\/S0002-9149(02)02499-2.","journal-title":"Am J Cardiol"},{"issue":"16","key":"112_CR14","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1001\/jama.285.16.2101","volume":"285","author":"DA Alter","year":"2001","unstructured":"Alter DA, Naylor CD, Austin PC, Tu JV: Long-term MI outcomes at hospitals with or without on-site revascularization. JAMA. 2001, 285 (16): 2101-2108. 10.1001\/jama.285.16.2101.","journal-title":"JAMA"},{"issue":"14","key":"112_CR15","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1001\/jama.1988.03410140100032","volume":"260","author":"S Yusuf","year":"1988","unstructured":"Yusuf S, Wittes J, Friedman L: Overview of results of randomised clinical trials in heart disease. I. Treaments following myocardial infarction. JAMA. 1988, 260 (14): 2088-2093. 10.1001\/jama.260.14.2088.","journal-title":"JAMA"},{"key":"112_CR16","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1001\/jama.1995.03520420066040","volume":"273","author":"R Garg","year":"1995","unstructured":"Garg R, Yusuf S: Overwiew of randomised trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE inhibitors trials. JAMA. 1995, 273: 1450-1456. 10.1001\/jama.273.18.1450.","journal-title":"JAMA"},{"key":"112_CR17","first-page":"1383","volume":"344","author":"Scandinavian Simvastatin Survival Study Group","year":"1994","unstructured":"Scandinavian Simvastatin Survival Study Group: Randomised trial of cholesterol lowering in 4,444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet. 1994, 344: 1383-1389.","journal-title":"Lancet"},{"key":"112_CR18","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","volume":"335","author":"FM Sacks","year":"1996","unstructured":"Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford J, Cole TG, Brown L, Warnica JW, Arnold JM, Wun CC, Davis BR, Braunwald E: The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 1996, 335: 1001-1009. 10.1056\/NEJM199610033351401.","journal-title":"N Engl J Med"},{"issue":"10","key":"112_CR19","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/S0735-1097(02)02477-4","volume":"40","author":"CA Allen Maycock","year":"2002","unstructured":"Allen Maycock CA, Muhlestein JB, Horne BD, Carlquist JF, Bair TL, Pearson RR, Li Q, Anderson JL, Intermountain Heart Collaborative S: Statin therapy is associated with reduced mortality across all age groups of individuals with significant coronary disease, including very elderly patients. Journal of the American College of Cardiology. 2002, 40 (10): 1777-1785. 10.1016\/S0735-1097(02)02477-4.","journal-title":"Journal of the American College of Cardiology"},{"issue":"9262","key":"112_CR20","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/S0140-6736(00)04257-4","volume":"357","author":"HD Aronow","year":"2001","unstructured":"Aronow HD, Topol EJ, Roe MT, Houghtaling PL, Wolski KE, Lincoff AM, Harrington RA, Califf RM, Ohman EM, Kleiman N, Keltai M, Wilcox RG, Vahanian A, Armstrong PW, Lauer MS: Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study. [see comment]. Lancet. 2001, 357 (9262): 1063-1068. 10.1016\/S0140-6736(00)04257-4.","journal-title":"Lancet"},{"issue":"8","key":"112_CR21","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S0002-9149(02)02236-1","volume":"89","author":"C Bickel","year":"2002","unstructured":"Bickel C, Rupprecht HJ, Blankenberg S, Espiniola-Klein C, Schlitt A, Rippin G, Hafner G, Treude R, Othman H, Hofmann KP, Meyer J, AtheroGene Investigators: Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease. American Journal of Cardiology. 2002, 89 (8): 901-908. 10.1016\/S0002-9149(02)02236-1.","journal-title":"American Journal of Cardiology"},{"issue":"7","key":"112_CR22","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.amjcard.2004.12.008","volume":"95","author":"TJ Bunch","year":"2005","unstructured":"Bunch TJ, Muhlestein JB, Bair TL, Renlund DG, Lappe DL, Jensen KR, Horne BD, Carter MA, Anderson JL, Intermountain Heart Collaborative Study G: Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure. American Journal of Cardiology. 2005, 95 (7): 827-831. 10.1016\/j.amjcard.2004.12.008.","journal-title":"American Journal of Cardiology"},{"issue":"4","key":"112_CR23","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S0735-1097(02)02013-2","volume":"40","author":"AW Chan","year":"2002","unstructured":"Chan AW, Quinn MJ, Bhatt DL, Chew DP, Moliterno DJ, Topol EJ, Ellis SG: Mortality benefit of beta-blockade after successful elective percutaneous coronary intervention. Journal of the American College of Cardiology. 2002, 40 (4): 669-675. 10.1016\/S0735-1097(02)02013-2.","journal-title":"Journal of the American College of Cardiology"},{"issue":"2","key":"112_CR24","first-page":"115","volume":"29","author":"C Coletta","year":"1999","unstructured":"Coletta C, Ricci R, Ceci V, Seccareccia F, Rulli F, Mazzuca V, Putini RL, Salustri A, Bottero G, Pasquale M: Effects of early treatment with captopril and metoprolol singly or together on six-month mortality and morbidity after acute myocardial infarction. Results of the RIMA (Rimodellamento Infarto Miocardico Acuto) study. The RIMA researchers. [see comment]. Giornale Italiano di Cardiologia. 1999, 29 (2): 115-124. discussion 125\u2013119","journal-title":"Giornale Italiano di Cardiologia"},{"issue":"4","key":"112_CR25","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1034\/j.1600-6143.2003.08062.x","volume":"16","author":"K Ellis","year":"2003","unstructured":"Ellis K, Tcheng JE, Sapp S, Topol EJ, Lincoff AM: Mortality benefit of beta blockade in patients with acute coronary syndromes undergoing coronary intervention: pooled results from the Epic, Epilog, Epistent, Capture and Rapport Trials. Journal of Interventional Cardiology. 2003, 16 (4): 299-305. 10.1034\/j.1600-6143.2003.08062.x.","journal-title":"Journal of Interventional Cardiology"},{"issue":"4","key":"112_CR26","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1067\/mhj.2003.1","volume":"145","author":"W Hague","year":"2003","unstructured":"Hague W, Forder P, Simes J, Hunt D, Tonkin A, LIPID Investigators: Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study. American Heart Journal. 2003, 145 (4): 643-651. 10.1067\/mhj.2003.1.","journal-title":"American Heart Journal"},{"issue":"6","key":"112_CR27","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1016\/S0735-1097(00)00950-5","volume":"36","author":"BD Horne","year":"2000","unstructured":"Horne BD, Muhlestein JB, Carlquist JF, Bair TL, Madsen TE, Hart NI, Anderson JL: Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease. [see comment]. Journal of the American College of Cardiology. 2000, 36 (6): 1774-1780. 10.1016\/S0735-1097(00)00950-5.","journal-title":"Journal of the American College of Cardiology"},{"issue":"2","key":"112_CR28","first-page":"115","volume":"114","author":"L Liu","year":"2001","unstructured":"Liu L, Chinese Cardiac Study Collaborative G: Long-term mortality in patients with myocardial infarction: impact of early treatment with captopril for 4 weeks. Chinese Medical Journal. 2001, 114 (2): 115-118.","journal-title":"Chinese Medical Journal"},{"issue":"4","key":"112_CR29","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S1388-9842(02)00099-5","volume":"4","author":"JE Otterstad","year":"2002","unstructured":"Otterstad JE, Ford I: The effect of carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction. How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with previous beta-blocker trials?. European Journal of Heart Failure. 2002, 4 (4): 501-506. 10.1016\/S1388-9842(02)00099-5.","journal-title":"European Journal of Heart Failure"},{"issue":"4","key":"112_CR30","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1001\/jama.285.4.430","volume":"285","author":"U Stenestrand","year":"2001","unstructured":"Stenestrand U, Wallentin L, Swedish Register of Cardiac Intensive C: Early statin treatment following acute myocardial infarction and 1-year survival. JAMA. 2001, 285 (4): 430-436. 10.1001\/jama.285.4.430.","journal-title":"JAMA"},{"issue":"5","key":"112_CR31","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.amjcard.2005.04.029","volume":"96","author":"GC Fonarow","year":"2005","unstructured":"Fonarow GC, Wright RS, Spencer FA, Fredrick PD, Dong W, Every N, French WJ, National Registry of Myocardial Infarction 4 Investigators: Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality. Am J Cardiol. 2005, 96 (5): 611-6. 10.1016\/j.amjcard.2005.04.029.","journal-title":"Am J Cardiol"},{"issue":"10","key":"112_CR32","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1111\/j.1532-5415.2004.52455.x","volume":"52","author":"BM Psaty","year":"2004","unstructured":"Psaty BM, Anderson M, Kronmal RA, Tracy RP, Orchard T, Fried LP, Lumley T, Robbins J, Burke G, Newman AB, Furberg CD: The association between lipid levels and the risks of incident myocardial infarction, stroke, and total mortality: The Cardiovascular Health Study. J Am Geriatr Soc. 2004, 52 (10): 1639-47. 10.1111\/j.1532-5415.2004.52455.x.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"112_CR33","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0002-9149(97)00320-2","volume":"80","author":"WS Aronow","year":"1997","unstructured":"Aronow WS, Ahn C, Kronzon I: Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction > or = 40% treated with diuretics plus angiotensin-converting enzyme inhibitors. Am J Cardiol. 1997, 80 (2): 207-9. 10.1016\/S0002-9149(97)00320-2.","journal-title":"Am J Cardiol"},{"issue":"1","key":"112_CR34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/eurheartj\/18.1.41","volume":"18","author":"JG Cleland","year":"1997","unstructured":"Cleland JG, Erhardt L, Murray G, Hall AS, Ball SG: Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators. Eur Heart J. 1997, 18 (1): 41-51.","journal-title":"Eur Heart J"},{"issue":"3","key":"112_CR35","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/0895-4356(94)00145-G","volume":"48","author":"JP Matts","year":"1995","unstructured":"Matts JP, Buchwald H, Fitch LL, Campos CT, Varco RL, Campbell GS, Pearce MB, Yellin AE, Smink RD, Sawin HS, Long JM, for The Posch Group: Subgroup analyses of the major clinical endpoints in the Program on the Surgical Control of the Hyperlipidemias (POSCH): overall mortality, atherosclerotic coronary heart disease (ACHD) mortality, and ACHD mortality or myocardial infarction. J Clin Epidemiol. 1995, 48 (3): 389-405. 10.1016\/0895-4356(94)00145-G.","journal-title":"J Clin Epidemiol"},{"issue":"9326","key":"112_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","volume":"360","author":"Heart Protection Study Collaborative Group","year":"2002","unstructured":"Heart Protection Study Collaborative Group: MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002, 360 (9326): 7-22. 10.1016\/S0140-6736(02)09327-3.","journal-title":"Lancet"},{"issue":"1","key":"112_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/00019501-200102000-00009","volume":"12","author":"J Herlitz","year":"2001","unstructured":"Herlitz J, Dellborg M, Karlson BW, Lindqvist J, Karlsson T, Sanden W, Sjolin M, Wedel H: Changes in the use of medications after acute myocardial infarction: possible impact on mortality after myocardial infarction and long-term outcome. Coronary Artery Disease. 2001, 12 (1): 61-67. 10.1097\/00019501-200102000-00009.","journal-title":"Coronary Artery Disease"},{"issue":"5","key":"112_CR38","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.amjcard.2003.11.027","volume":"93","author":"A Hognestad","year":"2004","unstructured":"Hognestad A, Dickstein K, Myhre E, Snapinn S, Kjekshus J, OPTIMAAL Investigators: Effect of combined statin and beta-blocker treatment on one-year morbidity and mortality after acute myocardial infarction associated with heart failure. American Journal of Cardiology. 2004, 93 (5): 603-606. 10.1016\/j.amjcard.2003.11.027.","journal-title":"American Journal of Cardiology"},{"issue":"6","key":"112_CR39","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1081\/JDI-200037110","volume":"26","author":"MW Krause","year":"2004","unstructured":"Krause MW, Massing M, Kshirsagar A, Rosamond W, Simpson RJ: Combination therapy improves survival after acute myocardial infarction in the elderly with chronic kidney disease. Renal Failure. 2004, 26 (6): 715-725. 10.1081\/JDI-200037110.","journal-title":"Renal Failure"},{"key":"112_CR40","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1161\/01.CIR.0000112577.69066.CB","volume":"109","author":"D Mukherjee","year":"2004","unstructured":"Mukherjee D, Fang J, Chetcuti S, Moscucci M, Kline-Rogers E, Eagle KA: Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes. Circulation. 2004, 109: 745-9. 10.1161\/01.CIR.0000112577.69066.CB.","journal-title":"Circulation"},{"issue":"11","key":"112_CR41","first-page":"1277","volume":"15","author":"AR Levy","year":"1999","unstructured":"Levy AR, Tamblyn RM, Fitchett D, McLeod PJ, Hanley JA: Coding accuracy of hospital discharge data for elderly survivors of myocardial infarction. Can J Cardiol. 1999, 15 (11): 1277-82.","journal-title":"Can J Cardiol"},{"key":"112_CR42","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1046\/j.1525-1497.1999.10198.x","volume":"14","author":"LA Petersen","year":"1999","unstructured":"Petersen LA, Wright S, Normand SL, Daley J: Positive predictive value of the diagnosis of acute myocardial infarction in an administrative database. J Gen Intern Med. 1999, 14: 555-8. 10.1046\/j.1525-1497.1999.10198.x.","journal-title":"J Gen Intern Med"},{"issue":"12","key":"112_CR43","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/S0895-4356(96)00271-5","volume":"49","author":"W D'Hoore","year":"1996","unstructured":"D'Hoore W, Bouckaert A, Tilquin C: Practical considerations on the use of the Charlson Comorbidity index with administrative data bases. J Clin Epidemiology. 1996, 49 (12): 1429-33. 10.1016\/S0895-4356(96)00271-5.","journal-title":"J Clin Epidemiology"},{"key":"112_CR44","volume-title":"Applied Logistic Regression","author":"DW Hosmer","year":"1989","unstructured":"Hosmer DW, Lemeshow S: Applied Logistic Regression. 1989, New York: Wiley & Sons"},{"key":"112_CR45","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/oxfordjournals.aje.a117347","volume":"141","author":"HP Zhang","year":"1995","unstructured":"Zhang HP, Bracken M: Tree-based risk factor analysis of preterm delivery and small-for-gestational-age birth. Am J Epidemiol. 1995, 141: 70-8.","journal-title":"Am J Epidemiol"},{"key":"112_CR46","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/(SICI)1097-0258(19960115)15:1<37::AID-SIM144>3.0.CO;2-0","volume":"15","author":"HP Zhang","year":"1996","unstructured":"Zhang HP, Holford T, Bracken M: A tree-based method in prospective studies. Stat Med. 1996, 15: 37-50. 10.1002\/(SICI)1097-0258(19960115)15:1<37::AID-SIM144>3.0.CO;2-0.","journal-title":"Stat Med"},{"issue":"9","key":"112_CR47","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.2337\/diacare.21.9.1439","volume":"21","author":"A Nicolucci","year":"1998","unstructured":"Nicolucci A, Carinci F, Ciampi A: Stratifying patients at risk of diabetic complications: An integrated look at clinical, socioeconomic and care-related factors. Diabetes Care. 1998, 21 (9): 1439-44.","journal-title":"Diabetes Care"},{"key":"112_CR48","volume-title":"Classification and Regression Trees","author":"L Breiman","year":"1984","unstructured":"Breiman L, Friedman JH, Olshen RA, Stone C: Classification and Regression Trees. 1984, Belmont, CA: Wadsworth International Group"},{"key":"112_CR49","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/0169-2607(88)90004-1","volume":"26","author":"A Ciampi","year":"1988","unstructured":"Ciampi A, Hogg S, McKinney S, Thiffault J: RECPAM: a computer program for recursive partition and amalgamation for censored survival data and other situations frequently occurring in biostatistics. I. Methods and program features. Comput Methods Programs Biomed. 1988, 26: 239-56. 10.1016\/0169-2607(88)90004-1.","journal-title":"Comput Methods Programs Biomed"},{"issue":"6","key":"112_CR50","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2143\/AC.55.6.2005767","volume":"55","author":"G de Gevigney","year":"2000","unstructured":"de Gevigney G, Ecochard R, Colin C, Rabilloud M, Excoffier S, Cao D, Cheneau E, Milon H, Delahaye F, PRIMA group: Characteristics, management, and inhospital mortality of acute myocardial infarction in the \"real world\" in France \u2013 data from a large unselected cohort of 2,519 consecutive patients in a French region. Acta Cardiol. 2000, 55 (6): 357-66. 10.2143\/AC.55.6.2005767.","journal-title":"Acta Cardiol"},{"issue":"6","key":"112_CR51","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1067\/mhj.2002.122517","volume":"143","author":"HL Dauerman","year":"2002","unstructured":"Dauerman HL, Yarzebski J, Gore JM, Lessard D, Goldberg RJ: Use of the invasive management strategy for patients with non-Q-wave myocardial infarction: an observational database report from the Worcester Heart Attack Study. Am Heart J. 2002, 143 (6): 1033-9. 10.1067\/mhj.2002.122517.","journal-title":"Am Heart J"},{"issue":"4","key":"112_CR52","first-page":"255","volume":"5","author":"G Amit","year":"2003","unstructured":"Amit G, Goldman S, Ore L, Low M, Kark JD: The association between hospital department, medical treatment and outcome in acute myocardial infarction. Isr Med Assoc J. 2003, 5 (4): 255-9.","journal-title":"Isr Med Assoc J"},{"issue":"9","key":"112_CR53","doi-asserted-by":"crossref","first-page":"465","DOI":"10.5694\/j.1326-5377.2001.tb143678.x","volume":"175","author":"IA Scott","year":"2001","unstructured":"Scott IA, Coory MD, Harper CM: The effects of quality improvement interventions on inhospital mortality after acute myocardial infarction. Med J Aust. 2001, 175 (9): 465-70.","journal-title":"Med J Aust"},{"issue":"5","key":"112_CR54","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1001\/archinte.161.5.737","volume":"161","author":"K Sheikh","year":"2001","unstructured":"Sheikh K, Bullock C: Urban-rural differences of care for medicare patients with acute myocardial infarction. Arch Intern Med. 2001, 161 (5): 737-53. 10.1001\/archinte.161.5.737.","journal-title":"Arch Intern Med"},{"key":"112_CR55","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1136\/jech.54.8.590","volume":"54","author":"HD Vu","year":"2000","unstructured":"Vu HD, Heller RF, Lim LLY, D'este C, O'Connell RL: Mortality after acute myocardial infarction is lower in metropolitan regions than in non-metropolitan regions. J Epidemiol Community Health. 2000, 54: 590-5. 10.1136\/jech.54.8.590.","journal-title":"J Epidemiol Community Health"},{"issue":"1","key":"112_CR56","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1467-842X.1999.tb01206.x","volume":"23","author":"LLY Lim","year":"1999","unstructured":"Lim LLY, O'Connell RL, Heller RF: Differences in management of heart attack patients between metropolitan and regional hospitals in the Hunter Region of Australia. Aust New Zeal J Pub Health. 1999, 23 (1): 61-6.","journal-title":"Aust New Zeal J Pub Health"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2261-6-21\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-6-21.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-6-21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-6-21.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T12:41:16Z","timestamp":1586868076000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/1471-2261-6-21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,4]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["112"],"URL":"https:\/\/doi.org\/10.1186\/1471-2261-6-21","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,4]]},"article-number":"21"}}